Nanoform Capacity Update October 2023: Small Molecule

This presentation from the October 2023 Outsourced Pharma Capacity Update introduces Nanoform, its CESS technology for nanoparticle generation, and the types of particles that can be generated without the need for solvents or excipients. Case studies show how nanoparticles can enable either faster onset of oral medications or extend the therapeutic window of long-acting implants depending on the chosen formulation. Finally, Nanoform’s manufacturing capabilities, including ongoing and planned GMP expansion for highly-potent APIs, are discussed with reference to potential production volumes.